Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)

SHE:300497 Revenue

Jiangxi Fushine Pharmaceutical had revenue of 530.49M CNY in the quarter ending June 30, 2026, with 88.80% growth. This brings the company's revenue in the last twelve months to 1.56B, up 54.30% year-over-year. In the year 2025, Jiangxi Fushine Pharmaceutical had annual revenue of 1.18B with 0.61% growth.

• Revenue (ttm): 1.56B
• Revenue Growth: +54.30%
• P/S Ratio: 6.91
• Revenue / Employee: n/a
• Employees: 1,663
• Market Cap: 10.76B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.18B	7.14M	0.61%
Dec 31, 2024	1.18B	-431.82M	-26.83%
Dec 31, 2023	1.61B	-37.59M	-2.28%
Jan 1, 2023	1.65B	217.72M	15.23%
Jan 1, 2022	1.43B	-63.41M	-4.25%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error